Chemomab Therapeutics CMMB
NASDAQ CMMB
$1.17 0.00 (-0.42%)
As of: Oct 21, 2026 · 3:30 PM EDT

Chemomab Therapeutics (CMMB) Operating Interest Expenses (2018 - 2019)

Updated

Chemomab Therapeutics (CMMB) recorded Operating Interest Expenses of $12.58 million in Q3 2019, compared with $72,000 a year earlier.

Analysis

Chemomab Therapeutics (CMMB) Operating Interest Expenses (2018 - 2019) Analysis & Trends

On a TTM basis, Chemomab Therapeutics' Operating Interest Expenses came in at $12.46 million as of Sep 30, 2019; for FY2018, it was $741,000, up 705.4% from FY2017.

  • Across earlier years, Operating Interest Expenses came in at $92,000 in FY2017 and $7,000 in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Interest Exp. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Chemomab Therapeutics 7.49 Mn -27.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 12.58 Mn
Jun 30, 2019 18,000.00
Dec 31, 2018 -212,000.00
Sep 30, 2018 72,000.00
Jun 30, 2018 806,000.00
API Access

Chemomab Therapeutics Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-interest-expenses&ticker=CMMB&period=max&api_key=YOUR_API_KEY